Clinical trials

  • Dacomitinib for Non-small cell lung cancer | EGFR mutation-positive non-small cell lung cancer
  • Ipilimumab for Metastatic colorectal cancer (dMMR/MSI)
  • Regorafenib for Ewing's sarcoma | Osteosarcoma | Refractory primary bone tumors
  • METFORMIN HYDROCHLORIDE for Polycystic ovary syndrome
  • LIDOCAINE HYDROCHLORIDE MONOHYDRATE for Inflammatory bowel disease | Crohn's disease | Ulcerative colitis
  • etidronate disodium for Fahr's disease | Fahr's syndrome
  • DATOPOTAMAB DERUXTECAN for EGFR-mutated non-small cell lung cancer | Non-squamous non-small cell lung cancer
  • ZANIDATAMAB for Biliary tract cancer | Gallbladder cancer | Intrahepatic cholangiocarcinoma | Extrahepatic cholangiocarcinoma
  • SELINEXOR for Multiple myeloma|Penta-refractory multiple myeloma|Triple-class refractory multiple myeloma|Relapsed/refractory multiple myeloma
  • SAVOLITINIB for Non-small cell lung cancer
  • METFORMIN HYDROCHLORIDE for Myotonic dystrophy type 1 | Steinert disease
  • Atezolizumab for Squamous cell carcinoma of the anal canal